In line with this evidence, another study in human HCC linked activated mTOR signaling to poor prognosis and survival of HCC patients, suggesting an important role of PI3K/AKT/mTOR signaling in HCC progression [133]. Here, MTOR is linked to hepatocellular carcinoma.